Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes.
Musto P, Lanza F, Balleari E, Grossi A, Falcone A, Sanpaolo G, Bodenizza C, Scalzulli PR, La Sala A, Campioni D, Ghio R, Cascavilla N, Carella AM.
Musto P, et al. Among authors: scalzulli pr.
Br J Haematol. 2005 Jan;128(2):204-9. doi: 10.1111/j.1365-2141.2004.05288.x.
Br J Haematol. 2005.
PMID: 15638854
Free article.